Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone morphogenetic proteins in vascular calcification.

Keith A Hruska1, Suresh Mathew, Georges Saab

  • 1Renal Division, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA. hruska_k@kids.wustl.edu

Circulation Research
|July 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Western Diet High in Phosphate Primes the Development of the CKD-Mineral Bone Disorder in an Alport Syndrome Model.

Kidney360·2026
Same author

Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis.

BMC neurology·2025
Same author

The Impact of a Western Diet High in Phosphate on the CKD-MBD in an Alport Syndrome Model.

bioRxiv : the preprint server for biology·2025
Same author

Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2024
Same author

Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study.

Multiple sclerosis and related disorders·2024
Same author

In chronic kidney disease altered cardiac metabolism precedes cardiac hypertrophy.

American journal of physiology. Renal physiology·2024

Bone morphogenetic proteins (BMPs) like BMP-2 and BMP-7 play roles in vascular calcification, a common issue in chronic kidney disease (CKD). BMP-7 shows promise in reversing calcification by regulating vascular smooth muscle cells and serum phosphate.

Area of Science:

  • Biochemistry
  • Nephrology
  • Cardiovascular Biology

Background:

  • Vascular calcification is prevalent in elderly individuals, and those with chronic kidney disease (CKD) and diabetes.
  • Vascular calcification in CKD involves phenotypic changes in vascular smooth muscle cells (VSMCs), leading to extracellular matrix mineralization.
  • Bone morphogenetic proteins (BMPs) are implicated in bone formation and their presence at vascular calcification sites suggests a role.

Purpose of the Study:

  • To review the actions of BMPs in vascular calcification.
  • To explore the specific roles of BMP-2 and BMP-7 in the context of CKD-related vascular calcification.

Main Methods:

  • Literature review focusing on BMP-2 and BMP-7 in vascular calcification.
  • Analysis of studies investigating BMPs' effects on VSMC phenotype, differentiation, and apoptosis.

Related Experiment Videos

  • Examination of BMP-7's impact on skeletal remodeling and serum phosphate levels in CKD models.

    • Main Results:

    • BMP-2's role in vascular calcification is studied but not definitively proven; it may induce VSMC osteoblastic differentiation or apoptosis.
    • BMP-7, primarily expressed in the kidney, may counteract vascular calcification in CKD.
    • BMP-7 has demonstrated ability to restore skeletal balance and reduce serum phosphate in CKD models, also reversing vascular calcification through direct VSMC actions and phosphate reduction.

    Conclusions:

    • BMPs, particularly BMP-7, represent potential therapeutic targets for vascular calcification in CKD.
    • BMP-7's multifaceted actions on VSMCs and phosphate metabolism offer a promising avenue for treating vascular complications in CKD.